Status:

COMPLETED

Brain and Stress Study

Lead Sponsor:

University of North Carolina, Chapel Hill

Collaborating Sponsors:

Robert Wood Johnson Foundation

Conditions:

Stress, Psychological

Motivation

Eligibility:

All Genders

25-60 years

Phase:

PHASE4

Brief Summary

Motivational deficits such as anhedonia are core to several psychiatric disorders and underlie significant functional impairment. This double-blind, placebo-controlled crossover trial of minocycline, ...

Detailed Description

This study seeks to conduct translational work that extends rich preclinical findings to the clinical domain to validate whether neuroinflammatory dysregulation is strongly tied to anhedonia. This pro...

Eligibility Criteria

Inclusion

  • 25-60 years old
  • Unemployed (working less than 20 hours per week)
  • Have been unemployed for at least 6 months
  • Seeking employment
  • Having trouble finding a job (i.e., actively seeking and applying for jobs but not successful in landing a job)
  • Reports greater than 5 points on Job Stress Items
  • Regular access to a mobile phone

Exclusion

  • Self-reported physical illnesses: diabetes, cardiovascular diseases, high blood pressure, inflammatory bowel diseases, rheumatoid arthritis, asthma, autoimmune disease, Crohn's disease, ulcerative colitis, lupus
  • neurological conditions (e.g., Traumatic Brain Injury, stroke)
  • pregnant (as measured by urine pregnancy screen) or breastfeeding
  • current use of psychotropic medications
  • Current regular recreational drug or alcohol use (i.e., 4 or more times per week)
  • chronic diseases that significantly impact inflammatory markers (e.g., cancer)
  • known allergies or hypersensitivities to tetracycline antibiotics, aspirin or other NSAIDs
  • current antibiotic use
  • regular use of steroidal or non-steroidal anti-inflammatory medications (i.e., 2 or more times a week)

Key Trial Info

Start Date :

September 12 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 19 2023

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT06044090

Start Date

September 12 2022

End Date

December 19 2023

Last Update

December 18 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Howell Hall

Chapel Hill, North Carolina, United States, 27599